Medicine & TechnologyA recent study suggests that relevant crystals conglomerates can aid medicinal chemists in forming new drugs. Learn here how that is possible. Read now!
Artificial intelligence (AI) models have used deep learning algorithms for a variety of applications in the past decades. Now, a new AI tool could help analyze pharmaceutical drugs and predict their future properties.
Scientists from the Multidisciplinary Association for Psychedelic Studies (MAPS) are hoping to help 18 terminally ill patients relieve their anxiety, depression, and fear in the next year during extended psychotherapy sessions enhanced by MDMA (ecstasy). The Marin County-based double-blind trial will see subjects test either full doses of MDMA (125 milligrams) or active placebo doses (30 milligrams).
It seems that cup of joe may be doing more than providing you with that morning pick me up afterall, especially if you are a woman. Scientists have found that coffee may actually protect women against breast cancer. According to researchers, coffee actually inhibits the growth of tumors and reduces the risk of recurrence in women who have been diagnosed with breast cancer and treated with the drug tamoxifen.
It seems the trends have begun to change. In an increasingly competitive work environment the pressure to perform in many white collar jobs has skyrocketed. To cope with the situation and perform even better, many white collar job workers have turned to the support of ADHD drugs to help them focus and increase their productivity.
In light of promising results conducted by an independent data monitoring committee, Pfizer’s newest treatment IBRANCE (Palbociclib) ended clinical trials early this week as phase 3 of the trials ended demonstrating improvement in progression-free survival in women who had undergone treatment for metastatic breast cancer.
According to a report from the IMS Institute for Healthcare Informatics , Americans spent more money on drugs than they ever have before with spending jumping by 13% to $374 billion, driven by innovative but expensive new drugs designed to treat Hepatitis C.
Though advances in HIV research and treatment have come to find ways of mitigating the virus, the disease continues to affects millions worldwide. And when the virus moves quickly, so does fear. In light of the discovery of a new strain of HIV, many are left wondering—could you too be at risk for contracting the disease?
In a new study published in the journal EBioMedicine, researchers with Belgium’s University of Leuvan report the discovery of a new strain of HIV which may prove to be far more lethal to patients in the West. Originally found in patients in Cuba, the new strain poses particular threats to those infected with HIV as it can develop into AIDS within three years of infection. Though efforts have significantly lowered the infection rates of HIV, as well as prolonged lives with the help of antiretroviral drugs, researchers fear that the fast-moving virus may advance too quickly to treat.
Antibiotic-resistant bacteria has become a growing problem around the country for both doctors and hospitals, causing an estimated 2 million illnesses and 23,000 deaths around the United States each year. And in an effort to combat these resistant forms of bacteria, the Obama administration wants to double the amount of federal funding dedicated to fighting these superbugs.
A new study has linked the use of common medications, including many over-the-counter treatments for conditions such as insomnia or even hay fever, to dementia.
A new study published in the journal Cancer reveals that many women with breast cancer in the United States don't actually know much about their condition, with minority women being less likely to report accurate information about their tumors than Caucasian women.
The experimental ZMapp treatment created by Mapp Biopharmaceutical will soon begin human clinical tries in the United States and Liberia, following efforts to boost production capacity.